The stock market on Thursday morning, as investors. Trade disputes still loom as a potential threat to the bull market, although many are hopeful that a resolution is possible. Earnings season is about to begin, with some bracing for weaker bottom-line growth than in 2018. As of 11:30 a.m. EDT, the Dow Jones Industrial Average (DJINDICES: ^ DJI) What up 25 points to 26,182. The S & P 500 (SNPINDEX: ^ GSPC) gained 3 points to 2,891, and the Nasdaq Composite (NASDAQINDEX: ^ IXIC) rose 2 points to 7,967.  Shareholders in Amazon.com (NASDAQ: AMZN) CEO Jeff Bezos, and it included some useful information not just about e-commerce and cloud computing giant, but also about broader thinking about the current state of the business community. At the same time, Rite Aid (NYSE: RAD) is published in the New York Stock Exchange
How Amazon keeps moving forward
19659009] Amazon.com's stock was changed Thursday morning as investors got their chance to enjoy the latest annual installment of its CEO's letter to shareholders. ” src=”https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F518847%2Famzn-prime-vans.jpg&w=700&op=resize”/>
More broadly, Bezos noted that several of Amazon's most successful offerings were not actually asked for. Along the way, Amazon produced some monumental failures – but Bezos accepts the greater scale of failure than the necessary price for a greater scale of success. Amazon.com is trying to move forward on multiple fronts and hopes to see the same positive results it has enjoyed throughout its history.
Rite Aid goes into reverse
Shares of Rite Aid plunged 11% following two news releases from the drugstore retail chain. Late Wednesday, the company said that it would be a 1-for-20 reverse stock split, essentially cutting the number of shares each shareholder by 95% but boosting the per-share price 20-fold. By doing so, Rite Aid hopes to comply with New York Stock Exchange Rules that require to maintain prices above $ 1 per share. Rite Aid shares will fall from more than 1 billion to just 54 million.
Separately, Rite Aid will release fourth-quarter financial results a modest drop in revenue. CEO John Standley blamed a mild flu season for part of his sluggishness, but he was optimistic about a rise in immunization activity, Medicare Part D membership, and continued efforts to become more healthcare-oriented in his operations.
The track record among stellar, but there have been some that have managed to beat the odds. Rite Aid still faces uphill climb as it aims to make the most of its remaining network of drugstore locations, and wants to sign up for it